EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MHC class II+ macrophage differentiation is impaired in metastasized lungs via PGE2 receptor EP2

Mi Reu Jeong, Jung Woo Hwang, Murim Choi, Seung Hyeok Seok

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.115574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Mi Reu Jeong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Macrophage Lab, Department of Microbiology and Immunology, and Institute of Endemic Disease, Seoul National University College of Medicine, Seoul 030…. Hauptthemen laut MEDLINE: Macrophages, Receptors, Prostaglandin E, EP2 Subtype, Cell Differentiation, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NRF, Korea Ministry of Trade Industry and Energy, Korea Drug Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monocytes differentiate into macrophages (Mφs) to facilitate lung metastasis, but the monocyte-to-Mφ transition during this process is not well understood. To investigate, we performed bulk RNA sequencing on Mφs isolated from the lungs of mice bearing Lewis lung carcinoma tumors and from naive lungs. Our results showed impaired differentiation of monocytes into major histocompatibility complex (MHC) class II+ Mφs, with an upregulation of PGE2-inducible genes, including Arg1, in tumor-associated Mφs (TAMs). In vitro experiments confirmed that prostaglandin E2 (PGE2) inhibits the differentiation of MHC class II+ Mφs while promoting Arg1+ Mφs via the E prostanoid 2 (EP2) receptor, accompanied by DNA methylation. Whole-genome bisulfite sequencing revealed that PGE2-EP2 signaling drives the hypermethylation and downregulation of gene sets related to myeloid cells in non-neoplastic tissues. Our study highlights PGE2-EP2-driven DNA methylation in the monocyte-to-TAM transition, suggesting potential therapeutic avenues for lung metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesReceptors, Prostaglandin E, EP2 SubtypeCell DifferentiationLung NeoplasmsHistocompatibility Antigens Class IIAnimalsMiceDinoprostoneMice, Inbred C57BLDNA MethylationMonocytesCarcinoma, Lewis LungLung

Stichwörter der Autor:innen

Arg1 macrophagesCP: CancerCP: ImmunologyDNA methylationEP2MHC-II macrophageslung metastasismacrophage differentiationmonocyte-to-macrophage transitionprostaglandin E(2)tumor-associated macrophage

Substanzen

Receptors, Prostaglandin E, EP2 SubtypeDinoprostoneHistocompatibility Antigens Class II

Autor:innen und Institutionen

  • Macrophage Lab, Department of Microbiology and Immunology, and Institute of Endemic Disease, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Macrophage Lab, Department of Microbiology and Immunology, and Institute of Endemic Disease, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Biomedical Sciences, Seoul Nation…

Förderung

  • NRF
  • Korea Ministry of Trade Industry and Energy
  • Korea Drug Development Fund
  • Ministry of Health and Welfare

Zitieren

APA

Jeong, M. R., Hwang, J. W., Choi, M., & Seok, S. H. (2025). MHC class II+ macrophage differentiation is impaired in metastasized lungs via PGE2 receptor EP2. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115574

Vancouver

Jeong MR, Hwang JW, Choi M, Seok SH. MHC class II+ macrophage differentiation is impaired in metastasized lungs via PGE2 receptor EP2. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115574

BibTeX
@article{Jeong2025,
  author = {Jeong, Mi Reu and Hwang, Jung Woo and Choi, Murim and Seok, Seung Hyeok},
  title = {MHC class II+ macrophage differentiation is impaired in metastasized lungs via PGE2 receptor EP2},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.115574}
}
Kostenlos starten →